Quantification of Circulating Endothelial Progenitor Cells Using the Modified ISHAGE Protocol (original) (raw)
Figure 3
Responses of circulating endothelial progenitor cells (CD45dimCD34+KDR+/leukocytes) in patients treated with de novo 40 mg atorvastatin/day.
The left bar indicates the number of progenitor cells before statin therapy, the right bar after 4 weeks of treatment.